Skip to content

Lessening Incontinence by Learning Yoga

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01672190
Acronym
LILY
Enrollment
20
Registered
2012-08-24
Start date
2012-08-31
Completion date
2012-12-31
Last updated
2013-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Over Active Bladder, Stress Urinary Incontinence, Urge Urinary Incontinence, Urinary Incontinence

Brief summary

The purpose of this study is to assess the feasibility of recruiting women with urinary incontinence into a randomized controlled trial of a yoga therapy program.

Interventions

OTHERYoga Therapy Program

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women aged 40 years or older who report urinary incontinence for \> 3 months prior to screening * Self-report at least 7 urinary incontinence episodes per week on a screening 7-day voiding diary * Self-report urgency-predominant, stress-predominant, or mixed-type incontinence on the screening voiding diary * Willing to refrain from initiating medical treatments that may affect their incontinence or voiding pattern during the study period * Capable of understanding study procedures and giving informed consent

Exclusion criteria

* Participation in a yoga class or other formal or organized yoga instruction in the past year * Any prior yoga therapy directed specifically at improving urinary incontinence or pelvic floor dysfunction * Current use of medical therapy or device (i.e. pessary) for incontinence or use within the previous month * Currently pregnant, gave birth within the past 6 months, or planning pregnancy during the study period * Current urinary tract infection or a history or 3 or more urinary tract infections in the preceding year * Report history of neurologic conditions such as stroke, multiple sclerosis, spinal cord injury, or Parkinson's disease, or a lumbosacral spine condition associated with neurological symptoms * Unable to walk up a flight of stairs or at least 2 blocks on level ground without assistance * Unable to get up from a supine to a standing position in 10 seconds or less and without assistance * Severe obesity, defined as body mass index \> 35 kg/m2 on screening examination * Report history of interstitial cystitis, fistula or hole in bladder or rectum, or birth defect leading to urine leakage * Report any history of prior anti-incontinence or urethral surgery (not including urethral dilation), pelvic cancer, or pelvic irradiation for any reason * Report use of bladder botox, electrostimulation, bladder training, or pelvic floor exercise training (with certified practitioners) in the past 3 months * Report other surgery to the pelvis (hysterectomy, oophorectomy, vaginal surgery, bladder surgery, colon surgery) within the past 3 months * Report symptomatic pelvic organ prolapse * Report history of vulvodynia, chronic pelvic pain, or pain when practicing pelvic floor exercises * Report conditions that, in the judgment of the investigators, render potential participants unlikely to follow the protocol, including plans to move, substance abuse, significant psychiatric problems, or dementia * Participation in another research study that involves investigational drugs or devices that could potentially confound the results of this study

Design outcomes

Primary

MeasureTime frame
Change in the number of incontinence episodes over 7 days, with 95% confidence intervals, between baseline and 6 weeks6 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026